Hepatitis C Prevalence in HIV Patients in Uganda
Author Information
Author(s): J. I. O'Reilly, P. Ocama, C. K. Opio, A. Alfred, E. Paintsil, E. Seremba, A. N. Sofair
Primary Institution: Yale University School of Medicine
Hypothesis
Are HIV-positive patients more likely to have hepatitis C infection compared to HIV-negative patients?
Conclusion
The study found that only 2.6% of patients tested positive for hepatitis C antibodies, with no significant difference between HIV-positive and HIV-negative patients.
Supporting Evidence
- Only 2.6% of the 500 patients tested positive for HCV antibodies.
- There was no significant difference in HCV antibody detection between HIV-positive and HIV-negative patients.
- Age over 50 was the only risk factor significantly associated with HCV infection.
Takeaway
The study looked at how many people in Uganda have hepatitis C, especially those with HIV, and found that not many people tested positive.
Methodology
Blood samples were tested for HCV antibodies, and positive tests were confirmed with HCV RNA PCR; a questionnaire was administered to gather demographic and clinical data.
Potential Biases
Potential for false positives and negatives in antibody testing due to the use of tests not validated for African sera.
Limitations
The study's confirmatory testing may have been affected by RNA degradation during transport, and the sample size for some risk factors was not sufficiently powered to achieve statistical significance.
Participant Demographics
The median age of participants was 35 years, with 47% male and half HIV-positive.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website